SARA UNDERWOOD-STANKEVICH: Open Payments
NPI 1033515697 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 108 payments from 23 companies in 2025. Trend: 2023 $2,285 · 2024 $2,330 · 2025 $2,140
Food & beverage: $2,140
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $386 |
| AstraZeneca Pharmaceuticals LP | 15 | $283 |
| ABBVIE INC. | 9 | $224 |
| Lilly USA, LLC | 14 | $179 |
| Vanda Pharmaceuticals Inc. | 5 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| PFIZER INC. | 5 | $97 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Abbott Laboratories | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
Products named: Wegovy, MOUNJARO, AIRSUPRA, FANAPT, UBRELVY, CAPLYTA, BREZTRI, Auvelity.
Industry payments across MI — which companies pay providers there.
